10/23, 1:29 PM (Source: TeleTrader)
more TeleTrader news

CureVac reports positive data for COVID vaccine

CureVac N.V. announced on Friday data from preclinical studies of its coronavirus vaccine showed positive results in mice and hamsters.

According to the biopharmaceutical company, the vaccine "elicited balanced humoral and cellular immune responses" inducing strong antibody levels. The data has been submitted for peer review.

"The preclinical data published today show that our COVID-19 vaccine candidate has the potential to induce an efficacious and balanced immune response, mimicking the natural immune defense and providing lung protection in a relevant challenge model," Chief Technology Officer Dr. Mariola Fotin-Mleczek said in the press release.

Shares of the company jumped 7.48% at 1:38 pm CET following the release.

Breaking the News / MD